As unemployment rates climb in the United States, employers are ordering fewer pre-employment drugs of abuse (DOA) screening panels. This is expected. It is why investors know that drugs-of-abuse volumes are closely linked to the economic boom/bust cycle. During first quarter earning calls, public lab companies revealed the bad news in this sector of lab […]
To access this post, you must purchase The Dark Report.